These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 18756431

  • 1. 17alpha-hydroxy-progesterone effects on cervical proinflammatory agents in women at risk for preterm delivery.
    Facchinetti F, Dante G, Venturini P, Paganelli S, Volpe A.
    Am J Perinatol; 2008 Sep; 25(8):503-6. PubMed ID: 18756431
    [Abstract] [Full Text] [Related]

  • 2. Non-infected preterm parturition is related to increased concentrations of IL-6, IL-8 and MCP-1 in human cervix.
    Törnblom SA, Klimaviciute A, Byström B, Chromek M, Brauner A, Ekman-Ordeberg G.
    Reprod Biol Endocrinol; 2005 Aug 25; 3():39. PubMed ID: 16122384
    [Abstract] [Full Text] [Related]

  • 3. Preterm labor is induced by intraamniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model.
    Sadowsky DW, Adams KM, Gravett MG, Witkin SS, Novy MJ.
    Am J Obstet Gynecol; 2006 Dec 25; 195(6):1578-89. PubMed ID: 17132473
    [Abstract] [Full Text] [Related]

  • 4. Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate.
    Facchinetti F, Paganelli S, Comitini G, Dante G, Volpe A.
    Am J Obstet Gynecol; 2007 May 25; 196(5):453.e1-4; discussion 421. PubMed ID: 17466698
    [Abstract] [Full Text] [Related]

  • 5. Cervical ripening and parturition in cows are driven by a cascade of pro-inflammatory cytokines.
    van Engelen E, de Groot MW, Breeveld-Dwarkasing VN, Everts ME, van der Weyden GC, Taverne MA, Rutten VP.
    Reprod Domest Anim; 2009 Oct 25; 44(5):834-41. PubMed ID: 19769639
    [Abstract] [Full Text] [Related]

  • 6. Pro-inflammatory and anti-inflammatory cytokines in human preterm and term cervical ripening.
    Dubicke A, Fransson E, Centini G, Andersson E, Byström B, Malmström A, Petraglia F, Sverremark-Ekström E, Ekman-Ordeberg G.
    J Reprod Immunol; 2010 Mar 25; 84(2):176-85. PubMed ID: 20096464
    [Abstract] [Full Text] [Related]

  • 7. The use of 17 alpha-hydroxyprogesterone caproate (17p) in women with cervical cerclage.
    Rebarber A, Cleary-Goldman J, Istwan NB, Rhea DJ, Desch C, Russo-Stieglitz K, Saltzman DH.
    Am J Perinatol; 2008 May 25; 25(5):271-5. PubMed ID: 18401840
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological use of progesterone and 17-alpha-hydroxyprogesterone caproate in the prevention of preterm delivery.
    Facchinetti F, Vaccaro V.
    Minerva Ginecol; 2009 Oct 25; 61(5):401-9. PubMed ID: 19749671
    [Abstract] [Full Text] [Related]

  • 9. Levels of cytokines (IL-1beta, IL-2, IL-6, IL-8, TNF-alpha) and trace elements (Zn, Cu) in breast milk from mothers of preterm and term infants.
    Ustundag B, Yilmaz E, Dogan Y, Akarsu S, Canatan H, Halifeoglu I, Cikim G, Aygun AD.
    Mediators Inflamm; 2005 Dec 14; 2005(6):331-6. PubMed ID: 16489252
    [Abstract] [Full Text] [Related]

  • 10. Microbiological characteristics and inflammatory cytokines associated with preterm labor.
    Discacciati MG, Simoes JA, Silva MG, Marconi C, Brolazo E, Costa ML, Cecatti JG.
    Arch Gynecol Obstet; 2011 Mar 14; 283(3):501-8. PubMed ID: 20237933
    [Abstract] [Full Text] [Related]

  • 11. Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial.
    Rozenberg P, Chauveaud A, Deruelle P, Capelle M, Winer N, Desbrière R, Perrotin F, Bohec C, Connan L, Vayssière C, Langer B, Mantel A, Azimi S, Porcher R, Azria E, Groupe De Recherche En Obstétrique et Gynécologie.
    Am J Obstet Gynecol; 2012 Mar 14; 206(3):206.e1-9. PubMed ID: 22381603
    [Abstract] [Full Text] [Related]

  • 12. Gestational age at initiation of 17-hydroxyprogesterone caproate (17P) and recurrent preterm delivery.
    González-Quintero VH, Istwan NB, Rhea DJ, Smarkusky L, Hoffman MC, Stanziano GJ.
    J Matern Fetal Neonatal Med; 2007 Mar 14; 20(3):249-52. PubMed ID: 17437227
    [Abstract] [Full Text] [Related]

  • 13. Pro-labour myometrial gene expression: are preterm labour and term labour the same?
    Tattersall M, Engineer N, Khanjani S, Sooranna SR, Roberts VH, Grigsby PL, Liang Z, Myatt L, Johnson MR.
    Reproduction; 2008 Apr 14; 135(4):569-79. PubMed ID: 18367515
    [Abstract] [Full Text] [Related]

  • 14. No effect of tocolytic therapy with atosiban on maternal serum interleukin-6 and tumor necrosis factor-alpha in threatened preterm labor.
    Vitoratos N, Kountouris A, Makrakis E, Papadias K, Creatsas G.
    J Matern Fetal Neonatal Med; 2007 Oct 14; 20(10):725-8. PubMed ID: 17763273
    [Abstract] [Full Text] [Related]

  • 15. Inflammatory cytokine mRNA detection by real time PCR in chorioamniotic membranes from pregnant women with preterm premature rupture of membranes.
    Polettini J, Peraçoli JC, Candeias JM, Araújo Júnior JP, Silva MG.
    Eur J Obstet Gynecol Reprod Biol; 2009 May 14; 144(1):27-31. PubMed ID: 19272692
    [Abstract] [Full Text] [Related]

  • 16. 17 hydroxyprogesterone for the prevention of preterm delivery.
    Meis PJ, Society for Maternal-Fetal Medicine.
    Obstet Gynecol; 2005 May 14; 105(5 Pt 1):1128-35. PubMed ID: 15863556
    [Abstract] [Full Text] [Related]

  • 17. Elevated interleukin-8 in cervical mucus as an indicator for treatment to prevent premature birth and preterm, pre-labor rupture of membranes: a prospective study.
    Sakai M, Sasaki Y, Yoneda S, Kasahara T, Arai T, Okada M, Hosokawa H, Kato K, Soeda Y, Saito S.
    Am J Reprod Immunol; 2004 Mar 14; 51(3):220-5. PubMed ID: 15209391
    [Abstract] [Full Text] [Related]

  • 18. The interleukin-1 beta +3953 single nucleotide polymorphism: cervical protein concentration and preterm delivery risk.
    Edwards RK, Ferguson RJ, Duff P.
    Am J Reprod Immunol; 2006 Apr 14; 55(4):259-64. PubMed ID: 16533337
    [Abstract] [Full Text] [Related]

  • 19. The value of interleukin-8, interleukin-6 and interleukin-1beta in vaginal wash as predictors of preterm delivery.
    González Bosquet E, Ferrer I, Valls C, Borrás M, Lailla JM.
    Gynecol Obstet Invest; 2005 Apr 14; 59(3):175-8. PubMed ID: 15746552
    [Abstract] [Full Text] [Related]

  • 20. Does progesterone treatment influence risk factors for recurrent preterm delivery?
    Meis PJ, Klebanoff M, Dombrowski MP, Sibai BM, Leindecker S, Moawad AH, Northen A, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S.
    Obstet Gynecol; 2005 Sep 14; 106(3):557-61. PubMed ID: 16135587
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.